Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Riley

Showing results (431-440 of 480) with videos related to

Pageof 48
Sort By:
The Lancet. Microbe|June 29, 2025
Clostridioides difficile should be considered a bacterial priority pathogenWiep Klaas Smits, Kevin W Garey, Thomas V Riley, et al.
New Microbes and New Infections|October 31, 2014
Epidemiology of Clostridium difficile infection in two tertiary-care hospitals in Perth, Western Australia: a cross-sectional studyN F Foster, D A Collins, S L Ditchburn, et al.
Anaerobe|April 17, 2025
Clostridioides (Clostridium) difficile in hospitalised children in CambodiaLengsea Eng, Kefyalew Addis Alene, Deirdre A Collins, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|December 25, 2015
25-Hydroxyvitamin D Concentrations and Clostridium difficile Infection: A Meta-AnalysisLuis Furuya-Kanamori, Kinley Wangdi, Laith Yakob, et al.
Elife|June 11, 2021
Major genetic discontinuity and novel toxigenic species in <i>Clostridioides difficile</i> taxonomyDaniel R Knight, Korakrit Imwattana, Brian Kullin, et al.
Journal of Clinical Microbiology|November 4, 2016
Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and CommunitiesLuis Furuya-Kanamori, Thomas V Riley, David L Paterson, et al.
ACS Omega|March 7, 2022
Development of 1,2,4-Oxadiazole Antimicrobial Agents to Treat Enteric Pathogens within the Gastrointestinal TractNoel P Pitcher, Jitendra R Harjani, Yichao Zhao, et al.
Infection Control and Hospital Epidemiology|January 31, 2015
Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: a systematic review and meta-analysisLuis Furuya-Kanamori, Jennifer C Stone, Justin Clark, et al.
Journal of Applied Microbiology|June 9, 2023
Environmental contamination with Clostridioides (Clostridium) difficile in VietnamPeng An Khun, Long Duc Phi, Huong Thi Thu Bui, et al.
Anaerobe|May 7, 2015
Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, AustraliaKate E Mackin, Briony Elliott, Despina Kotsanas, et al.
Pageof 48

Showing results (431-440 of 480) with videos related to

Sort By:
Pageof 48
The Lancet. Microbe|June 29, 2025
Clostridioides difficile should be considered a bacterial priority pathogenWiep Klaas Smits, Kevin W Garey, Thomas V Riley, et al.
New Microbes and New Infections|October 31, 2014
Epidemiology of Clostridium difficile infection in two tertiary-care hospitals in Perth, Western Australia: a cross-sectional studyN F Foster, D A Collins, S L Ditchburn, et al.
Anaerobe|April 17, 2025
Clostridioides (Clostridium) difficile in hospitalised children in CambodiaLengsea Eng, Kefyalew Addis Alene, Deirdre A Collins, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|December 25, 2015
25-Hydroxyvitamin D Concentrations and Clostridium difficile Infection: A Meta-AnalysisLuis Furuya-Kanamori, Kinley Wangdi, Laith Yakob, et al.
Elife|June 11, 2021
Major genetic discontinuity and novel toxigenic species in <i>Clostridioides difficile</i> taxonomyDaniel R Knight, Korakrit Imwattana, Brian Kullin, et al.
Journal of Clinical Microbiology|November 4, 2016
Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and CommunitiesLuis Furuya-Kanamori, Thomas V Riley, David L Paterson, et al.
ACS Omega|March 7, 2022
Development of 1,2,4-Oxadiazole Antimicrobial Agents to Treat Enteric Pathogens within the Gastrointestinal TractNoel P Pitcher, Jitendra R Harjani, Yichao Zhao, et al.
Infection Control and Hospital Epidemiology|January 31, 2015
Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: a systematic review and meta-analysisLuis Furuya-Kanamori, Jennifer C Stone, Justin Clark, et al.
Journal of Applied Microbiology|June 9, 2023
Environmental contamination with Clostridioides (Clostridium) difficile in VietnamPeng An Khun, Long Duc Phi, Huong Thi Thu Bui, et al.
Anaerobe|May 7, 2015
Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, AustraliaKate E Mackin, Briony Elliott, Despina Kotsanas, et al.
Pageof 48